Literature DB >> 16473944

Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.

Sayuri Yamazaki1, Munjal Patel, Alice Harper, Anthony Bonito, Hidehiro Fukuyama, Maggi Pack, Kristin V Tarbell, Mia Talmor, Jeffrey V Ravetch, Kayo Inaba, Ralph M Steinman.   

Abstract

Thymic-derived CD25+ CD4+ T regulatory cells (Tregs) suppress immune responses, including transplantation. Here we evaluated the ability of dendritic cells (DCs) to expand alloantigen-specific Tregs in the mixed leukocyte reaction (MLR) that develops from polyclonal populations of T cells. The allogeneic DCs, when supplemented with IL-2 in the cultures, were much more effective than bulk spleen cells in expanding the numbers of Tregs. Likewise, DCs and not spleen cells were effective in sustaining expression of the transcription factor Foxp3 in Tregs, but neither IL-2 nor CD80/86 was required for this effect in the cultures. On a per-cell basis, the DC-expanded, but not unexpanded, Tregs were more potent suppressors of a fresh MLR by CD25- CD4+ T cells. Suppression was 3- to 10-fold more active for MLRs induced by the original alloantigens than for third-party stimulators. When DC-expanded Tregs were introduced into sublethally irradiated hosts, the T cells suppressed graft-versus-host-disease induced by CD25- CD4+ T cells. Again, suppression was more active against the same mouse strain that provided the DCs to expand the Tregs. Therefore, alloantigen-selected Tregs are more effective suppressors of responses to major transplantation antigens, and these Tregs can be expanded from a polyclonal repertoire by DCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473944      PMCID: PMC1413800          DOI: 10.1073/pnas.0510606103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

3.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

4.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Authors:  J Shimizu; S Yamazaki; S Sakaguchi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 5.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

6.  CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.

Authors:  P A Taylor; R J Noelle; B R Blazar
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

7.  Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

Authors:  Megan K Levings; Romina Sangregorio; Claudia Sartirana; Anna Lisa Moschin; Manuela Battaglia; Paul C Orban; Maria-Grazia Roncarolo
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

8.  Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

Authors:  Detlef Dieckmann; Cord Henrik Bruett; Heidi Ploettner; Manfred Bernhard Lutz; Gerold Schuler
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

9.  Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Petra Hoffmann; Joerg Ermann; Matthias Edinger; C Garrison Fathman; Samuel Strober
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

10.  CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Authors:  José L Cohen; Aurélie Trenado; Douglas Vasey; David Klatzmann; Benoît L Salomon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  67 in total

1.  Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells.

Authors:  Li Liu; Lihua Duan; Min Gong; Hong Dai; Quan Gong; Fang Zheng; Zheng Tan; Congyi Wang; Feili Gong; Min Fang
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

2.  Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.

Authors:  Hua Yang; Elaine Y Cheng; Vijay K Sharma; Mila Lagman; Christina Chang; Ping Song; Ruchuang Ding; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

3.  Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

Authors:  Nicolas Degauque; Christophe Mariat; James Kenny; Dong Zhang; Wenda Gao; Minh Diem Vu; Sophoclis Alexopoulos; Mohammed Oukka; Dale T Umetsu; Rosemarie H DeKruyff; Vijay Kuchroo; Xin Xiao Zheng; Terry B Strom
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.

Authors:  K L Pothoven; T Kheradmand; Q Yang; J L Houlihan; H Zhang; M Degutes; S D Miller; X Luo
Journal:  Am J Transplant       Date:  2010-07-12       Impact factor: 8.086

5.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

6.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.

Authors:  Christine Vogtenhuber; Matthew J O'Shaughnessy; Dario A A Vignali; Bruce R Blazar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 8.  Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Ralph M Steinman
Journal:  J Dermatol Sci       Date:  2009-03-14       Impact factor: 4.563

9.  Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance.

Authors:  Cherry Kingsley; Barry Peters; Kaboutar Babaahmady; Laura Pomeroy; Durdana Rahman; Robert Vaughan; Thomas Lehner
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

10.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.